What is clear in all this, there were some winners and some loser in the deal to buy GDC-0084. We know have a highly sought after drug in the clinic. Sought out intail by a hugely successful entrepreneur. And we got it for what .........5 Million dollars plus commissions and milestone payments bringing the whole deal as it stands to day less than 9 Million dollars. Future payment and royalties to genetech are only if the drug is successfully and by then it simply will not matter. Serious name another company for an outlay of 10M has a drug in four clinical trials three of which are phase II, three of which are being primarily funded by the investigating hospital or NCI.
KZA Price at posting:
39.0¢ Sentiment: Buy Disclosure: Held
